vimarsana.com

அலுவலகம் ஆஃப் தி கீந் தொழில்நுட்பம் சீராக்கி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award For Customer Value Leadership

ADELAIDE, AUS, Aug 10, 2021 - (ACN Newswire) - Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second .

Access to GM crop innovation now available to all mainland Australian states

Date Time Access to GM crop innovation now available to all mainland Australian states Agri-biotech companies across all mainland Australian States now stand in-line with their global competitors, after the expiration of the NSW Government’s 18-year moratorium on genetically-modified crop innovations commenced this month. Having long-lasting and certainty of access to current and future GM crops approved for commercialisation will encourage stronger research and innovation, and support the sector’s abilities to reach the growing population’s needs. Access will be maintained to all GM crops that have been approved through the Office of the Gene Technology Regulator’s robust assessments.

International Trade in Crops with New Breeding Technologies: The Australian Perspective

International Trade in Crops with New Breeding Technologies: The Australian Perspective June 9, 2021 ISAAA and partners present the webinar International Trade in Crops with New Breeding Technologies: The Australian Perspective to provide an insight into the future landscape of trade involving gene-edited crops, particularly in relation to countries involved in the international trade of agricultural products. It will be held on June 11, 2021, at 2 PM Manila / 4 PM Sydney via Zoom. Developments in regulations of gene-edited plants are changing rapidly. Increasingly more countries, including Australia, have implemented deregulation of gene-edited crops. In Australia, this followed a series of reviews by the Office of the Gene Technology Regulator. Common approaches are also emerging among many other countries.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.